Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

19th Jan 2010 17:40

RNS Number : 8072F
Skyepharma PLC
19 January 2010
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

SKYEPHARMA PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

Delta adjustment

3. Full name of person(s) subject to the notification obligation:

D. E. SHAW & CO., L.P.

D. E. SHAW & CO. (U.K.) LTD.

 

4. Full name of shareholder(s) (if different from 3.):

N/A

 

5. Date of the transaction and date on which the threshold is crossed or reached:

JANUARY 15 2010

 

6. Date on which issuer notified:

JANUARY 19 2010

 

7. Threshold(s) that is/are crossed or reached:

36,35,34,33,32% 

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

 

 

 

 

 

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

 

 
 

C: Financial Instruments with similar economic effect to Qualifying Financial Instrumentsxv, xvi

 

Resulting situation after the triggering transaction

 

 
Type of financial instrument
Exercise price
Expiration
date xvii
Exercise/ Conversion period xvii
Number of voting rights instrument refers to

% of voting rightsxix xx

 

Contract for Differences
 

 

January 13, 2011

 

 

3,461,725

Nominal
Delta
("CfD") relating to convertible bond due 2024
 

14.46%

CfD relating to convertible bond due 2025
 
December 3, 2010
 
2,058,257
Nominal
Delta
8.60%
CfD relating to convertible bond due 2025
 
June 3, 2010
 
2,058,257
Nominal
Delta
8.60%

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

7,578,239

 

31.65% 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Each of D. E. Shaw & Co., L.P. ("DESCO LP") and D. E. Shaw & Co. (U.K.) Ltd ("DESCO UK") is notifying solely in its capacity as a discretionary investment manager. As general partner of DESCO LP, D. E. Shaw & Co., Inc. ("DESCO Inc.") is a parent undertaking of DESCO LP and DESCO UK. By virtue of David E. Shaw's position as president and sole shareholder of DESCO Inc., which is the general partner of DESCO LP, David E. Shaw is a parent undertaking of DESCO LP and DESCO UK.

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

Stephen Back (Compliance Department)

 

15. Contact telephone number:

+1 212 478 0000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDKLFFBFFBBBZ

Related Shares:

SKP.L
FTSE 100 Latest
Value8,554.80
Change23.19